Paul A. Offit, MD of @The Children’s Medical facility of Philadelphia returns to JAMA’s Q&A series to supply an update on the emergence of COVID-19 versions and their implications for vaccine advancement, including the JNJ vaccine, set up for a @U.
– Earn Free CME credits by viewing JAMA Livestreams and finishing a quick survey.
– Claim 0.5 credits for each video at https://ja.ma/covidqa
.- Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
.- To view all the #JAMALive Q&A’s Visit: https://ja.ma/covidqaytpl
.- Do not forget to hit subscribe or click https://ja.ma/subscribe
.
Subjects gone over in this interview:
0: 00 Intro
0: 24 Are we seeing natural and vaccine caused resistance?
3: 32 mRNA Vaccine safety update
6: 30 Variations and COVID vaccines
10: 28 Variants – concerns
12: 55 Broadly reducing the effects of vaccine for all variants
15: 18 Preparing for a virulent COVID-19 variation
16: 53 Johnson and Johnson vaccine
18: 52 Who should get the JnJ vaccine?
20: 32 Biologics License Application (BLA)
21: 18 Vaccine platforms and variations
22: 15 Negative events
23: 30 Anti-vaxxers and vaccine hesitancy
26: 16 Sputnik and other global vaccine efforts
30: 00 When will kids get a COVID vaccine?
32: 44 Mandating vaccines
———————————————————————————
For more from JAMA
– https://www.jama.com
– https://www.facebook.com/JAMAJournal
– https://www.twitter.com/JAMA_Current
– https://www.linkedin.com/company/jamanetwor
Follow the JAMA Network
– https://www.jamanetwork.com
– https://www.jamanetworkaudio.com
– https://www.facebook.com/JAMANetwork
– https://www.twitter.com/JAMANetwork
– https://www.instagram.com/JAMANetwork
– https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV 2 #Pandemic.
Comments
Post a Comment